Henry Schein, Inc. (NASDAQ:HSIC) Position Boosted by Isthmus Partners LLC

Isthmus Partners LLC grew its holdings in shares of Henry Schein, Inc. (NASDAQ:HSICFree Report) by 45.6% in the 4th quarter, HoldingsChannel.com reports. The firm owned 8,950 shares of the company’s stock after purchasing an additional 2,805 shares during the period. Isthmus Partners LLC’s holdings in Henry Schein were worth $678,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. JPMorgan Chase & Co. lifted its stake in Henry Schein by 1.1% during the third quarter. JPMorgan Chase & Co. now owns 4,766,305 shares of the company’s stock valued at $353,898,000 after buying an additional 53,506 shares in the last quarter. American Century Companies Inc. lifted its stake in Henry Schein by 7.3% during the third quarter. American Century Companies Inc. now owns 4,719,088 shares of the company’s stock valued at $350,392,000 after buying an additional 322,649 shares in the last quarter. Boston Partners lifted its stake in Henry Schein by 144.1% during the fourth quarter. Boston Partners now owns 2,637,429 shares of the company’s stock valued at $199,393,000 after buying an additional 1,556,831 shares in the last quarter. Northern Trust Corp lifted its stake in Henry Schein by 2.8% during the third quarter. Northern Trust Corp now owns 1,647,889 shares of the company’s stock valued at $122,356,000 after buying an additional 45,561 shares in the last quarter. Finally, Norges Bank purchased a new stake in Henry Schein during the fourth quarter valued at about $111,715,000. Institutional investors own 96.62% of the company’s stock.

Henry Schein Stock Performance

Shares of Henry Schein stock traded down $0.89 during midday trading on Thursday, hitting $69.25. The company had a trading volume of 1,219,830 shares, compared to its average volume of 1,076,446. The business’s 50 day simple moving average is $72.28 and its two-hundred day simple moving average is $73.19. The stock has a market cap of $8.87 billion, a PE ratio of 23.39, a P/E/G ratio of 1.78 and a beta of 0.87. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.75 and a quick ratio of 1.02. Henry Schein, Inc. has a 1-year low of $60.01 and a 1-year high of $82.63.

Henry Schein (NASDAQ:HSICGet Free Report) last announced its quarterly earnings data on Tuesday, May 7th. The company reported $1.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.01 by $0.09. The business had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.21 billion. Henry Schein had a net margin of 3.12% and a return on equity of 13.51%. Henry Schein’s quarterly revenue was up 3.7% on a year-over-year basis. During the same quarter last year, the company posted $1.21 earnings per share. As a group, equities analysts predict that Henry Schein, Inc. will post 5.08 EPS for the current fiscal year.

Insider Buying and Selling

In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of Henry Schein stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total transaction of $477,620.40. Following the completion of the transaction, the chief executive officer now directly owns 73,108 shares of the company’s stock, valued at $5,430,462.24. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of Henry Schein stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total transaction of $477,620.40. Following the completion of the transaction, the chief executive officer now directly owns 73,108 shares of the company’s stock, valued at $5,430,462.24. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Vice Chairman James P. Breslawski sold 2,907 shares of Henry Schein stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $74.37, for a total value of $216,193.59. Following the completion of the transaction, the insider now directly owns 209,562 shares of the company’s stock, valued at $15,585,125.94. The disclosure for this sale can be found here. 1.14% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

HSIC has been the subject of a number of analyst reports. Jefferies Financial Group upped their price objective on shares of Henry Schein from $74.00 to $81.00 and gave the company a “hold” rating in a research note on Wednesday, March 6th. SVB Leerink initiated coverage on shares of Henry Schein in a research note on Monday, February 26th. They set a “market perform” rating and a $78.00 price objective for the company. UBS Group reduced their price target on shares of Henry Schein from $82.00 to $80.00 and set a “neutral” rating for the company in a research report on Wednesday, May 8th. Barrington Research increased their price target on shares of Henry Schein from $90.00 to $92.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 8th. Finally, TheStreet raised shares of Henry Schein from a “c+” rating to a “b-” rating in a research report on Monday, February 26th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $81.73.

View Our Latest Research Report on HSIC

Henry Schein Profile

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Further Reading

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSICFree Report).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.